key: cord-0693630-lkkeepn6
authors: Huang, Josephine F.; Greenway, Melanie R.F.; Nasr, Deena M.; Chukwudelunzu, Felix E.; Demaerschalk, Bart M.; O’Carroll, Cumara B.; Nord, Charisse A.; Pahl, Emily A.; Barrett, Kevin M.; Williams, Lindsy N.
title: Telestroke in the Time of COVID-19: The Mayo Clinic Experience
date: 2020-06-13
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.06.007
sha: bfe9d8d9e82cfb177ac9fc0bd78f9751383a387d
doc_id: 693630
cord_uid: lkkeepn6

Abstract On March 11, 2020, the World Health Organization declared the coronavirus disease 2019 (COVID-19) a pandemic, and in the weeks following, public health organizations, medical associations, and governing bodies throughout the world recommended limiting contact with others to “flatten the curve” of COVID-19. Although both ischemic and hemorrhagic strokes have been reported with COVID-19, there has been anecdotal suggestion of an overall decrease in stroke admissions. To date, the effects of any pandemic on telestroke service lines have not been described. The purpose of this cross-sectional analysis of telestroke activations in the 30 days before and after the declaration of the COVID-19 pandemic is to describe the difference in case volumes of telestroke activations, the characteristics of patients, and treatment recommendations between the two time frames. We found a 50% reduction in total telestroke activations between the pre- and post- groups, 142 and 71, respectively. There were no statistically significant differences in age, sex, diagnosis, or regional variations in activation volumes. The percentage of patients in whom we recommended acute stroke treatment with intravenous alteplase, mechanical thrombectomy, or both, decreased from 44% to 33%. The reasons for the significant decrease in telestroke activations and acute stroke treatment recommendations are likely multifactorial, regardless, underscoring the importance of continued public health measures to encourage patients and families to seek emergent medical care at the time of symptom onset.

The World Health Organization (WHO) declared the coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020. The ultimate magnitude of impact from COVID-19 has yet to be seen in the United States. Neurologic manifestations of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been reported in 36.4% of the Wuhan cohort of COVID-19 patients, with ischemic and hemorrhagic stroke occurring in 5.7% of patients. 1 Anecdotally, the volumes of stroke admissions in some communities in the United States have recently decreased. 2 Prior studies during epidemics such as the Middle East respiratory syndrome (MERS) epidemic have demonstrated decreased Emergency Room (ER) utilization collectively. 3, 4 This brings into question whether patients may feel dissuaded from presenting to the hospital with mild or rapidly resolving symptoms-a situation that could be reflective of patients' anxieties during this daunting time. With this, we would anticipate that the volume of stroke patients with more severe deficits would still remain stable. However, Zhao et al report a reduction in thrombectomies in Shanghai by 50% in the first month after the Spring Festival when compared to the same time period in 2019. 5 Whether this reflects a reduction in patient volume, decreased eligibility due to delayed presentation, reluctance to perform a procedure that could potentially result in contamination or exposure, unavailability of specialized staff that may be ill or redeployed to another specialty, or simply the lack of resources or hospital capacity to carry out the procedures is unknown.

Because of the relatively new technology offered through current telestroke practices, the effects of a global pandemic on a telestroke service line have yet to be described. We aim to analyze the patterns of our telestroke population in the 30 days preceding the World Health Organization (WHO) declaration of the COVID-19 pandemic on March 11, 2020, compared to the 30 days following this declaration through a retrospective review of all telestroke activations from February 10, 2020, until April 9, 2020, at our 27 Mayo Clinic affiliated telestroke spoke hospitals.

A retrospective review of data collected for emergency department telestroke activations for 30 days prior to the pandemic declaration (February 10 -March 10, 2020) and 30 days post (March 11-April 9, 2020) from the Mayo Clinic telestroke network. This telestroke network provides 24-hour synchronous audio-video telestroke service to 27 hospitals located in Arizona, Florida, Iowa, Minnesota, and Wisconsin and is activated when an emergency department physician or advanced practice practitioner recognizes patients presenting with acute stroke symptoms and signs who may be amenable to acute stroke treatment. Data reviewed included patient age, sex, location, time of symptom onset or last known normal, time of telestroke activation, diagnoses, NIH stroke scale score, and recommendations for treatment with intravenous tissue plasminogen activator (IV-tPA), and/or endovascular thrombectomy.

Telestroke activation criteria for our institution are: 1) presence of any persistent focal neurological deficits presenting within 6 hours of stroke onset or last known normal, or 2) persistent neurological deficits with NIHSS > 6 presenting within 6-24 hours from stroke onset or last known normal time.

Continuous variables are reported as mean ± standard deviation. Continuous variables were compared using a student's t-test. Categorical variables are reported as N (%) and compared using a Chi-square test. All analyses were performed using JMP Pro 14.1 (www.jmp.com, Cary, NC).

There were 142 stroke activations in the pre-pandemic declaration period and 71 in the postpandemic declaration period-a 50% reduction in volume. The average number of telestroke activations per day decreased from 4.7 to 2.4. The number of patients in whom a telestroke video visit was completed with stroke as the final diagnosis decreased by 51%, from 65 to 33. There were no differences in age, sex, diagnosis, or regional variation in volume (Table 1) . Table 2 summarizes the clinical variables in patients with diagnosis of ischemic stroke only. While the proportion of ischemic stroke diagnosis volumes were similar pre-and postpandemic declaration, the last known normal/symptom onset time to telestroke activation in the ER was significantly shorter for the post-pandemic declaration group ( Figure 1 ). Recommendation for acute stroke intervention (IV-tPA and/or thrombectomy) occurred at a lower rate for our post-pandemic group. This is despite the findings of similar stroke severity in the two groups. Notably, however, all patients that did not receive acute stroke treatment in the post-pandemic declaration group had an NIHSS <6, with the majority of patients with an NIHSS < 3 (21/24, 87.5%).

Anecdotally from stroke centers internationally, overall stroke volumes appear to have decreased. 6 Several questions regarding this phenomenon include: 1) If the true incidence of stroke has decreased, 2) If patients with stroke or TIA are staying home due to COVID-19 exposure concern, 3) If patients are presenting too late for acute therapies and thus staying at their local hospital without telestroke activation or being transferred to a stroke center, 4) If decreased travel for medical appointments result in fewer stroke admissions, and 5) If fewer stroke mimics are presenting to the ER.

This retrospective review describes the telestroke activation patterns of the Mayo Clinic telestroke network in the 30 days preceding the declaration of the COVID-19 pandemic and the 30 days following. There was a notable reduction in average telestroke utilization from 4.7 to 2.4 activations per day, which was observed across all geographical regions of the telestroke network. The observed decrease in volumes at our spoke sites argues against a phenomenon that could be attributed to reluctance of community hospitals to refer to tertiary referral centers, or decreased acceptance of patients from the receiving tertiary centers. However, it remains unclear if the overall reduction in volume of telestroke activations was due to a reduced incidence of stroke, patient-related factors, or a reduction in utilization by ER providers. It is notable that similar reductions in volume have been seen for percutaneous coronary interventions in the setting of ST elevation myocardial infarction in the United States as well as reports from Spain.⁷ , 8 We found that the median time from reported symptom onset or last known normal time to telestroke activation was decreased in the post-pandemic declaration group compared to the pre-pandemic declaration group. This could potentially be explained by local stay-at-home orders that resulted in more witnessed strokes at home by family members, resulting in earlier presentation to the ER. Potentially, an overall decreased ER utilization for all medical conditions could also contribute to earlier telestroke activation. Additionally, there could be late-presenting patients who were not captured in our cohort due to presentation after 24 hours, thus not meeting criteria for telestroke activation. Despite this decreased time to telestroke activation, there was a reduction in the percentage of patients that received acute stroke interventions (IV-tPA and/or thrombectomy). We noted that most of the patients who did not receive treatment had low NIHSS scores, suggesting mild stroke symptoms. The data in this regard was difficult to interpret as details on potential exclusion factors were not included as part of this review, and the number of patients in this group was small. However, this remains an area that may require further exploration to determine if acute stroke treatment patterns are affected by the pandemic.

There were no other statistically significant variables between the pre-and post-pandemic declaration groups. Interestingly, age did not appear to differ between the two groups despite the increased morbidity associated with COVID-19 in the elderly population. Based on reports of reduced ER presentations for less severe conditions during the MERS epidemic, one may expect a reduction in the proportion of stroke mimics and TIAs compared to ischemic stroke diagnoses 3 . However, this was not observed in our cohort. While we did see a reduction in the proportion of stroke mimics in the post-group; this did not achieve statistical significance. Likewise, among those with a stroke diagnosis, NIHSS did not appear to be significantly different between the two groups.

A significant reduction in telestroke activations was seen in the 30 days following the WHO declaration of the COVID-19 pandemic. This mirrors early data regarding reduction of STsegment elevation myocardial infarction as well as single center reports of reduced stroke volumes and interventions globally. At this early stage, it is difficult to identify the underlying cause of this change and it may very well be multifactorial. Moving forward, it will be important to identify patient and provider factors that may contribute to underutilization of stroke emergency services. 

Last known normal time to telestroke activation. Group 1 = pre-pandemic declaration from February 10, 2020 until March 10, 2020; Group 2 = post-pandemic declaration from March 11, 2020 until April 9, 2020.

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic

Impact of the 2015 Middle East Respiratory Syndrome Outbreak on Emergency Care Utilization and Mortality in South Korea

The Impact of Middle East Respiratory Syndrome Outbreak on Trends in Emergency Department Utilization Patterns

Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) Outbreak. Stroke

The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era

Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States

Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiología intervencionista en España. REC Interv Cardiol

Last known normal time to telestroke activation. Group 1 = pre-pandemic declaration from February 10, 2020 until March 10, 2020; Group 2 = post-pandemic declaration from March 11, 2020 until April 9, 2020.